Safety and Feasibility of Transanal Endoscopic Surgery for Diffuse Cavernous Hemangioma of the Rectum
Joint Authors
Zeng, Ziwei
Wu, Xianrui
Chen, Junji
Luo, Shuangling
Hou, Yujie
Kang, Liang
Source
Gastroenterology Research and Practice
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-06-19
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Purpose.
To evaluate the safety and feasibility of transanal endoscopic surgery for diffuse cavernous hemangioma of the rectum (DCHR).
Methods.
All DCHR patients who underwent transanal endoscopic surgery in our hospital between January 2014 and June 2018 were reviewed.
Results.
A total of 7 patients with a diagnosis of DCHR underwent transanal endoscopic surgery during the study period.
Four patients (57.1%) were male, with a mean age at surgery of 34.5±7.7 years, and three patients (42.9%) were female, with a mean age at surgery of 29.9±3.8 years.
Recurrent painless rectal bleeding was the main symptom in all patients.
The mean age was 32 years old (range 21-54 years).
The median duration of symptoms was 10 years (range 1 month-50 years).
The level of hemoglobin at admission ranged from 59.0 to 148.0 g/l (mean 106.6 g/l), and the level of mean corpuscular volume (MCV) ranged from 75.1 fl to 93.5 fl (mean 83.7 fl).
Colonoscopy, computed tomography (CT), and magnetic resonance imaging (MRI) were important in the diagnosis of DCHR because of their high positive rates and accurate features.
All of the lesions are between the anal canal and the descending colon.
Two patients could be found with some enlarged serpentine vessels in the cervix, vagina, or corpus cavernosum by MRI.
After admission, all the patients underwent transanal endoscopic surgery and four patients had simultaneous loop ileostomy.
The mean operative time was 278 min (range 168-400 min).
The median amount of intraoperative blood loss was 50 ml (range 10-300 ml).
The mean distance from anal verge to anastomosis was 2.2±0.2 cm.
The anastomosis was fashioned with a stapler in two patients (28.6%).
There were no intraoperative and postoperative complications.
All the patients continued to recover well from the surgery, and nobody needed postoperative blood transfusions.
Conclusions.
The specific diagnosis rate of DCHR is low.
Preoperative MRI and CT examination can make a definitive diagnosis and determine the extent of the lesions.
DCHR is mostly restricted to the rectum, sigmoid colon, anal wall, and mesorectum.
The best treatment for DCHR is complete lesion resection.
It is safe and feasible to treat DCHR using transanal endoscopic surgery.
Moreover, transanal endoscopic surgery might have a huge potential when used to treat other rectal diseases.
American Psychological Association (APA)
Zeng, Ziwei& Wu, Xianrui& Chen, Junji& Luo, Shuangling& Hou, Yujie& Kang, Liang. 2019. Safety and Feasibility of Transanal Endoscopic Surgery for Diffuse Cavernous Hemangioma of the Rectum. Gastroenterology Research and Practice،Vol. 2019, no. 2019, pp.1-8.
https://search.emarefa.net/detail/BIM-1154830
Modern Language Association (MLA)
Zeng, Ziwei…[et al.]. Safety and Feasibility of Transanal Endoscopic Surgery for Diffuse Cavernous Hemangioma of the Rectum. Gastroenterology Research and Practice No. 2019 (2019), pp.1-8.
https://search.emarefa.net/detail/BIM-1154830
American Medical Association (AMA)
Zeng, Ziwei& Wu, Xianrui& Chen, Junji& Luo, Shuangling& Hou, Yujie& Kang, Liang. Safety and Feasibility of Transanal Endoscopic Surgery for Diffuse Cavernous Hemangioma of the Rectum. Gastroenterology Research and Practice. 2019. Vol. 2019, no. 2019, pp.1-8.
https://search.emarefa.net/detail/BIM-1154830
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1154830